A Study to Evaluate Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis
Clinical trial NCT06077331 · UNKNOWN
Trial details
- NCT number
- NCT06077331
- Sponsor
- Hansoh BioMedical R&D Company
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-28
- Primary completion
- 2024-07-31
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.